Taylor, A P <br/><br/>
Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement.  [electronic resource] 

 -  British journal of cancer  Jun 2010 
 - 82-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6605746  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actins--chemistry<br/>Breast Neoplasms--metabolism<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cytoskeleton--chemistry<br/>Female<br/>Humans<br/>Intermediate Filament Proteins--analysis<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3--metabolism<br/>Phosphatidylinositol 3-Kinases--physiology<br/>Phosphorylation<br/>Placenta Growth Factor<br/>Pregnancy Proteins--pharmacology<br/>Signal Transduction--drug effects<br/>Vascular Endothelial Growth Factor Receptor-1--physiology<br/>Vimentin--analysis